Sirop toux
Food supplement declared in France, declaration No 2020-6-413
Sirop toux is a food supplement declared in France. Status: retiré du marché le 1 June 2026. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- not provided
- Food business operator placing the product on the market
- Olisma
- Status
- Retiré du marché le 1 June 2026
- Form
- Sirop
- Daily dose
- 30 ml
- Directions for use
- prendre 2 cuillères à café 2 à 3 fois par jour (20 à 30 ml)
- Not recommended for (according to the manufacturer)
- Femmes allaitantes, Enfants (moins de 12 ans), Enfants en bas âge (1 à 3 ans), Femmes enceintes, Nourrissons (moins de 1 an), Utilisation prolongée
Declaration 313553, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retiré du marché le 1 June 2026, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Althaea officinalis L. | Racine | Extrait fluide hydroalcoolique | 300 mg |
| Plantago lanceolata L. | Feuille | Extrait fluide hydroalcoolique | 300 mg |
| Thymus vulgaris L. | Feuille | Extrait fluide hydroalcoolique | 300 mg |
| Eucalyptus globulus Labill. | Essence (feuille) | Distillation | 18 mg |
| Myrtus communis L. | Essence (feuille) | Distillation | 18 mg |
Other active ingredients
| Name | Per day |
|---|---|
| miel | not declared |
Additives
E330
Other ingredients
sirop de glucose-fructose, eau
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Déconseillé en cas de grossesse, allaitement et chez l’enfant de moins de 12 ans. Prendre l’attache d’un professionnel de santé avant tout usage. Demandez conseil à un professionnel de santé en cas de traitement antiépileptique ou d'antécédent de convulsion. Ne pas dépasser deux semaines de prise. Ne pas utiliser le produit en cas d’hypersensibilité envers un ou plusieurs composants.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- SIROP TOUX PHARMA SCIENCE, declared in 2024 : different composition: 5 ingredient(s) added, 8 missing
- SIROP TOUX IFIP, declared in 2018 : different composition: 8 ingredient(s) added, 6 missing